Eswatini vs Zimbabwe: Access to anti-retroviral drugs, female
Eswatini
98.0%
in 2024
Zimbabwe
98.0%
in 2024
Eswatini rank
1st
Zimbabwe rank
1st
Access to anti-retroviral drugs, female over time
- Eswatini
- Zimbabwe
How they compare
Eswatini currently reports 98.0% against 98.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Zimbabwe ahead.
Eswatini ranks 1st and Zimbabwe ranks 1st of 141 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.7% | 4.3% | 3.4% | Eswatini |
| 2010s | 64.4% | 63.8% | 0.6% | Eswatini |
| 2020s | 97.4% | 96.0% | 1.4% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Eswatini or Zimbabwe?
- Eswatini, at 98.0% against 98.0% in Zimbabwe as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Eswatini and Zimbabwe?
- 0.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do Eswatini and Zimbabwe rank globally for access to anti-retroviral drugs, female?
- Eswatini ranks 1st and Zimbabwe ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.